April 1, 2018Open Access

Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age

Key Points

Key points are not available for this paper at this time.

Abstract

Metformin or insulin for GDM was associated with similar offspring total and abdominal body fat percent and metabolic measures at 7-9 years. Metformin-exposed children were larger at 9 years. Metformin may interact with fetal environmental factors to influence offspring outcomes.

Bookmark

View Full Paper

Cite This Study

Rowan et al. (Sun,) studied this question.

synapsesocial.com/papers/69e458c8579ce7f542d37cd8 https://doi.org/https://doi.org/10.1136/bmjdrc-2017-000456

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A follow‐up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months2014 · 139 citations
2Metformin mitigates the impaired development of skeletal muscle in the offspring of obese mice2011 · 38 citations
3Birth Weight and Parental BMI Predict Overweight in Children From Mothers With Gestational Diabetes2005 · 218 citations
4Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes2005 · 3,154 citations
5Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy2004 · 253 citations

Bookmark

View Full Paper